Upgrade to SI Premium - Free Trial

Emergent BioSolutions (EBS)

7.50 -0.08 (1.06%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026 July 22, 2026 4:01 PM - StreetInsider Form EFFECT Erste Group Bank AG/ADR July 9, 2026 6:04 AM - SEC Filing Form 4 Emergent BioSolutions For: Jul 01 Filed by: Williams Paul Anthony July 2, 2026 12:57 PM - SEC Filing Form F-6 Erste Group Bank AG/ADR Filed by: JPMorgan Chase Bank, N.A. - ADR Depositary July 1, 2026 5:26 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony July 1, 2026 4:13 PM - SEC Filing Form 8-K Emergent BioSolutions For: Jun 26 June 29, 2026 11:15 AM - SEC Filing Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal June 29, 2026 9:13 AM - StreetInsider Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government June 29, 2026 9:13 AM - Globe NewsWire Form 4 Emergent BioSolutions For: Jun 08 Filed by: Williams Paul Anthony June 10, 2026 3:09 PM - SEC Filing Form 4 Emergent BioSolutions For: Jun 08 Filed by: LINDAHL RICHARD S June 10, 2026 3:08 PM - SEC Filing Form 4 Emergent BioSolutions For: Jun 08 Filed by: Glessner Coleen June 10, 2026 3:07 PM - SEC Filing Form 4 Emergent BioSolutions For: Jun 08 Filed by: Hartzel William June 10, 2026 3:06 PM - SEC Filing Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose June 4, 2026 8:02 AM - StreetInsider Benchmark Reiterates Buy Rating on Emergent BioSolutions (EBS) June 2, 2026 8:40 AM - StreetInsider Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy May 28, 2026 4:01 PM - StreetInsider Emergent BioSolutions to Participate in Upcoming Investor Conferences May 20, 2026 7:30 AM - Globe NewsWire Emergent BioSolutions gets Saudi approval for smallpox, mpox vaccine May 18, 2026 9:00 AM - StreetInsider Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live] May 18, 2026 8:59 AM - Globe NewsWire Form 4 Emergent BioSolutions For: Apr 30 Filed by: Dayal Sujata Tyagi May 4, 2026 5:31 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: DeGolyer Donald W May 4, 2026 5:30 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Katkin Keith May 4, 2026 5:30 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: White Marvin L May 4, 2026 5:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: FOWLER JOHN D JR May 4, 2026 5:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Richard Ronald May 4, 2026 5:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Zoon Kathryn C May 4, 2026 5:28 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Fowler Neal Franklin May 4, 2026 5:28 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 30 Filed by: Harsanyi Zsolt May 4, 2026 5:24 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Williams Paul Anthony May 1, 2026 4:30 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Lowry Simon C May 1, 2026 4:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Glessner Coleen May 1, 2026 4:29 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: LINDAHL RICHARD S May 1, 2026 4:28 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Perl Jessica May 1, 2026 4:27 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: Hartzel William May 1, 2026 4:27 PM - SEC Filing Form 4 Emergent BioSolutions For: Apr 29 Filed by: PAPA JOSEPH C May 1, 2026 4:26 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: Dayal Sujata Tyagi May 1, 2026 4:21 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: Zoon Kathryn C May 1, 2026 4:03 PM - SEC Filing Form 144 Emergent BioSolutions Filed by: DeGolyer Donald W May 1, 2026 4:03 PM - SEC Filing Form 10-Q Emergent BioSolutions For: Mar 31 May 1, 2026 9:34 AM - SEC Filing Emergent BioSolutions (EBS) Misses Q1 EPS by 65c May 1, 2026 2:02 AM - StreetInsider Form S-8 Emergent BioSolutions April 30, 2026 4:43 PM - SEC Filing Form 8-K Emergent BioSolutions For: Apr 30 April 30, 2026 4:35 PM - SEC Filing Emergent BioSolutions Reports First Quarter 2026 Financial Results April 30, 2026 4:30 PM - StreetInsider Form 144 Emergent BioSolutions Filed by: Katkin Keith April 30, 2026 4:16 PM - SEC Filing Emergent BioSolutions gains Singapore approval for ACAM2000 mpox indication April 30, 2026 7:55 AM - StreetInsider Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox April 30, 2026 7:55 AM - Globe NewsWire Form 8-K Emergent BioSolutions For: Apr 29 April 30, 2026 7:31 AM - SEC Filing Form SCHEDULE 13G Emergent BioSolutions Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 6:27 PM - SEC Filing Emergent BioSolutions signs $50 million manufacturing deal with SAB BIO April 29, 2026 7:35 AM - StreetInsider Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142 April 29, 2026 7:35 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Emergent BioSolutions (EBS) April 29, 2026 7:25 AM - StreetInsider Emergent BioSolutions partners with baseball player Davis Schneider for opioid awareness April 29, 2026 6:54 AM - StreetInsider Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives April 29, 2026 6:53 AM - Globe NewsWire Form DEFA14A Emergent BioSolutions April 28, 2026 3:09 PM - SEC Filing Emergent BioSolutions partners with Substipharm for JE vaccine manufacturing April 28, 2026 8:01 AM - StreetInsider Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States April 28, 2026 8:01 AM - StreetInsider Form DEFA14A Emergent BioSolutions April 27, 2026 4:55 PM - SEC Filing Full Article List